Sign in

Chubb Limited CB

Price 348.2 USD
as of 2026-09-05
60/100
No view
Quality54
Growth54
Balance-sheet strength59
Valuation68
Momentum66
Income48

Composite 60/100; the shares have moved about 21% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Income ranks 48/100 — a slight mark against it.

Case for

Valuation ranks 68/100 — a moderate point in its favour. Momentum ranks 66/100 — a moderate point in its favour. Balance-sheet strength ranks 59/100 — a slight point in its favour.

Case against

Income ranks 48/100 — a slight mark against it.

What the company does Chubb Limited (CB) is a global property and casualty insurer operating across six segments, including North America Commercial P&C, Overseas General, and Global Reinsurance. It offers property, liability, crop, marine, and personal accident insurance, alongside risk management services.

Key financials Key metrics: ROE 14.8%, ROA 3.3%, ROCE 4.9%; gross/operating/net margins 30.7%/23.5%/18.2%; revenue growth 6.0%, EPS growth -0.7%. Leverage is moderate (Debt/Equity 0.31), with strong interest coverage (14.87) but a low current ratio (0.41).

Stock health Momentum is strong: +32.47% over 12m, +13.18% over 6m, +9.63% over 3m. RSI(14) is 53.20, indicating neutral momentum. Sideravia scores Valuation 77.0 and Momentum 72.5, reflecting attractive valuation and positive price action.

Price vs fair value CB trades at a discount of 3.60% versus the analyst mean target of 365.26. Key drivers of the gap: - Recent headlines suggest valuation remains a concern despite growth (Zacks). - Leadership appointments at Tempest Re aim to bolster reinsurance growth (Simply Wall St.). - Q2 2026 earnings analysis indicates potential undervaluation (Simply Wall St.).

Looking forward Forward P/E is 13.19, below trailing P/E 12.89, implying modest earnings expectations. Dividend yield is 1.2% with a sustainable payout ratio (13.9%). Focus remains on underwriting discipline and reinsurance expansion to sustain ROE.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.